We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+12.3%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$51B
AUM Growth
+$15.4B
(+43%)
Cap. Flow
+$11.4B
Cap. Flow
% of AUM
22.45%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
2,383
New
382
Increased
1,739
Reduced
215
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$973M |
| 2 |
Microsoft
MSFT
|
+$944M |
| 3 |
Meta Platforms (Facebook)
META
|
+$686M |
| 4 |
Amazon
AMZN
|
+$561M |
| 5 |
NVIDIA
NVDA
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Leggett & Platt
LEG
|
+$127M |
| 2 |
PBCT
People's United Financial Inc
PBCT
|
+$25.8M |
| 3 |
Albemarle
ALB
|
+$25.2M |
| 4 |
CDW
CDW
|
+$25.2M |
| 5 |
Factset
FDS
|
+$23.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33% |
| 2 | Consumer Discretionary | 13.39% |
| 3 | Communication Services | 11.47% |
| 4 | Healthcare | 9.06% |
| 5 | Consumer Staples | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Supernus Pharmaceuticals
SUPN
$2.68B
| $578K | ﹤0.01% |
19,862
+843
| +4% | +$25.6K |
|
1352
ESCO Technologies
ESE
$8.49B
| $576K | ﹤0.01% |
6,403
+2,453
| +62% | +$212K |
|
|
CIVI
1353
DELISTED
Civitas Resources
CIVI
| $575K | ﹤0.01% |
11,732
+6,979
| +147% | +$371K |
|
|
BDN
1354
Brandywine Realty Trust
BDN
$551M
| $571K | ﹤0.01% |
42,474
+16,257
| +62% | +$223K |
|
1355
Enanta Pharmaceuticals
ENTA
$372M
| $570K | ﹤0.01% |
7,633
+384
| +5% | +$30.1K |
|
1356
Enpro
NPO
$7.05B
| $568K | ﹤0.01% |
5,158
+1,978
| +62% | +$199K |
|
|
CVET
1357
DELISTED
Covetrus, Inc. Common Stock
CVET
| $568K | ﹤0.01% |
28,448
+10,064
| +55% | +$189K |
|
1358
AbCellera Biologics
ABCL
$1.62B
| $567K | ﹤0.01% |
+39,653
| New | +$602K |
|
1359
Four Corners Property Trust
FCPT
$2.86B
| $567K | ﹤0.01% |
19,303
+7,583
| +65% | +$216K |
|
1360
First Financial Bancorp
FFBC
$3.55B
| $566K | ﹤0.01% |
23,198
+8,596
| +59% | +$208K |
|
1361
Popular Inc
BPOP
$11B
| $564K | ﹤0.01% |
6,884
-65
| -0.9% | -$5.27K |
|
1362
Integra LifeSciences
IART
$1.54B
| $564K | ﹤0.01% |
8,403
+1,658
| +25% | +$112K |
|
1363
Protagonist Therapeutics
PTGX
$8.75B
| $564K | ﹤0.01% |
16,489
+597
| +4% | +$18.9K |
|
|
OCDX
1364
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $563K | ﹤0.01% |
26,310
+12,123
| +85% | +$239K |
|
|
MGLN
1365
DELISTED
Magellan Health Services, Inc.
MGLN
| $563K | ﹤0.01% |
5,923
+2,268
| +62% | +$215K |
|
|
CPE
1366
DELISTED
Callon Petroleum Company
CPE
| $562K | ﹤0.01% |
11,895
+5,740
| +93% | +$307K |
|
|
MDRX
1367
DELISTED
Veradigm Inc. Common Stock
MDRX
| $562K | ﹤0.01% |
30,393
+11,283
| +59% | +$179K |
|
|
AXNX
1368
DELISTED
Axonics, Inc. Common Stock
AXNX
| $561K | ﹤0.01% |
10,014
+4,140
| +70% | +$253K |
|
|
FSR
1369
DELISTED
Fisker Inc.
FSR
| $561K | ﹤0.01% |
35,692
+14,751
| +70% | +$255K |
|
1370
Sunstone Hotel Investors
SHO
$2.19B
| $559K | ﹤0.01% |
47,633
+19,644
| +70% | +$235K |
|
1371
Adaptive Biotechnologies
ADPT
$3.56B
| $558K | ﹤0.01% |
19,874
-10,196
| -34% | -$313K |
|
|
WLL
1372
DELISTED
Whiting Petroleum Corporation
WLL
| $557K | ﹤0.01% |
8,606
+3,555
| +70% | +$233K |
|
1373
InterDigital
IDCC
$6.68B
| $553K | ﹤0.01% |
7,725
+2,965
| +62% | +$207K |
|
1374
Innospec
IOSP
$2.09B
| $553K | ﹤0.01% |
6,132
+2,353
| +62% | +$208K |
|
1375
CareTrust REIT
CTRE
$10.2B
| $552K | ﹤0.01% |
24,190
+9,316
| +63% | +$197K |
|
Similar funds
ProShare Advisors's Q4 2021 Portfolio in Review
As of Q4 2021, ProShare Advisors held 2,383 positions worth $51B, up 43% from $35.6B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
ProShare Advisors deployed $11.4B of net new capital in Q4 2021, opening 382 new positions and adding to 1,739 existing holdings. Its largest new stake was Lucid Motors: 272,628 shares worth $104M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Leggett & Platt, an estimated $127M trimmed.
- ProShare Advisors's largest Q4 2021 buy was Lucid Motors: 272,628 shares worth $104M.
- ProShare Advisors added most to Apple in Q4 2021, an estimated $973M increase.
- ProShare Advisors's biggest Q4 2021 reduction was Leggett & Platt, cutting an estimated $127M.
- ProShare Advisors fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $20.9M.
- ProShare Advisors's ten largest holdings make up 33% of its $51B portfolio in Q4 2021.
- ProShare Advisors opened 382 new positions and closed 45 in Q4 2021.
- ProShare Advisors's portfolio value rose 43% quarter-over-quarter to $51B.
Based on ProShare Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.